Tag: Cell

  • Restoring insulin sensitivity without TZD side effects

    Restoring insulin sensitivity without TZD side effects

    [ad_1]

    Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. While TZDs were extremely popular in the 1990’s and early 2000’s, they have fallen out of use among physicians in recent decades because they were discovered to cause unwanted side effects, including weight gain and excess fluid accumulation in body tissues.

    Now, researchers at University of California San Diego School of Medicine are exploring how to isolate the positive effects of these drugs, which could help yield new treatments that don’t come with the old side effects. In a new study published in Nature Metabolism, the researchers discovered how one of the most well-known TZD drugs works at the molecular level and were able to replicate its positive effects in mice without giving them the drug itself.

    For decades, TZDs have been the only drugs we have that can reverse insulin resistance, but we seldom use them anymore because of their side effects profile. Impaired insulin sensitivity is the root cause of type 2 diabetes, so any treatment we can develop to safely restore this would be a major step forward for patients.”


    Jerrold Olefsky, M.D., professor of medicine and assistant vice chancellor for integrative research at UC San Diego Health Sciences

    The main driver of insulin resistance in type 2 diabetes is obesity, which currently affects more than 40 percent of Americans and in 2021 bore an annual medical cost of nearly $173 billion. In addition to causing adipose tissue (fat) to expand, obesity also causes low levels of inflammation. This inflammation causes immune cells, called macrophages, to accumulate in adipose tissue, where they can comprise up to 40 percent of the total number of cells in the tissue.

    When adipose tissue is inflamed, these macrophages release tiny nanoparticles containing instructions for surrounding cells in the form of microRNAs, small fragments of genetic material that help regulate gene expression. These microRNA-containing capsules, called exosomes, are released into the circulation and can travel through the bloodstream to be absorbed by other tissues, such as the liver and muscles. This can then lead to the varied metabolic changes associated with obesity, including insulin resistance. For the current study, the researchers wanted to understand how TZD drugs, which restore insulin resistance, affect this exosome system.

    The researchers treated a group of obese mice with rosiglitazone, a type of TZD drug. Those mice became more sensitive to insulin, but they also gained weight and retained excess fluid, known side effects of rosiglitazone. However, by isolating exosomes from the adipose tissue macrophages of the mice who had received the drug and injecting them into another group of obese mice that had not received it, the researchers were able to deliver the positive effects of rosiglitazone without transferring the negative effects.

    “The exosomes were just as effective in reversing insulin resistance as the drug itself but without the same side effects,” said Olefsky. “This indicates that exosomes can ultimately link obesity-related inflammation and insulin resistance to diabetes. It also tells us that we may be able to leverage this system to boost insulin sensitivity.”

    The researchers were also able to identify the specific microRNA within the exosomes that was responsible for the beneficial metabolic effects of rosiglitazone. This molecule, called miR-690, could eventually be leveraged into new therapies for type 2 diabetes.

    “It’s likely not practical to develop exosomes themselves as a treatment because it would be difficult to produce and administer them, but learning what drives the beneficial effects of exosomes at the molecular level makes it possible to develop drugs that can mimic these effects,” said Olefsky. “There’s also plenty of precedent for using microRNAs themselves as drugs, so that’s the possibility we’re most excited about exploring for miR-690 going forward.” 

    Source:

    Journal reference:

    Rohm, T. V., et al. (2024). Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization. Nature Metabolism. doi.org/10.1038/s42255-024-01023-w.

    [ad_2]

    Source link

  • New microfluidic device improves the separation of tumor cells and clusters from malignant effusions

    New microfluidic device improves the separation of tumor cells and clusters from malignant effusions

    [ad_1]

    Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This novel technology promises to advance the diagnosis and treatment monitoring of cancer by enabling the high-throughput, continuous-flow ternary separation of single tumor cells, tumor cell clusters, and white blood cells (WBCs) from clinical pleural or abdominal effusions.

    Understanding the nature of malignant effusions, teeming with tumor cells and clusters, is critical in comprehending the breadth of cancer’s impact. The significant role of tumor clusters, with their heightened potential for metastasis compared to individual cells, cannot be overstated in the context of comprehensive cancer care. While traditional techniques have shown adeptness in isolating single tumor cells, they often fall short when it comes to tumor clusters, thus limiting the scope of clinical research. The evolution of microfluidic technologies has introduced high-throughput, label-free approaches for the separation of these cells, leveraging their physical characteristics for more precise analyses. However, the challenges presented by tumor cell clusters-;primarily their rarity and fragility-;call for innovative solutions to ensure their efficient yet careful separation, maintaining their viability for downstream applications.

    In response to this challenge, a team of researchers from Southeast University has unveiled a microfluidic device, designed to achieve the precise separation of tumor entities with unprecedented efficiency. These findings were detailed in an article (DOI: 10.1038/s41378-024-00661-0) published on March 12, 2024, in Microsystems & Nanoengineering. This research introduces a device that skillfully integrates slanted spiral channels with periodic contraction-expansion arrays.

    This design utilizes inertial forces to adeptly separate single tumor cells, tumor cell clusters, and WBCs from clinical samples of pleural or abdominal effusions-;key indicators of cancer metastasis. Operating at a brisk flow rate of 3500 µL/min, the device not only manages large volumes efficiently but also ensures an exceptionally high degree of separation accuracy. With over 94% of WBCs effectively removed, the recovery of more than 97% of tumor cells and the preservation of over 90% of vital tumor cell clusters, this technology heralds a new era in cancer diagnostics, facilitating early detection, prognosis evaluation, and the monitoring of treatment outcomes.

    Our device represents a substantial advancement in the analysis of malignant effusions. By efficiently isolating tumor cell clusters, known for their considerable metastatic potential, we’re forging new pathways for the early detection and treatment of cancer.”


    Professor Nan Xiang, the study’s lead author

    This innovation marks a significant milestone in the realm of cancer diagnostics, enhancing the efficiency and throughput of tumor cell and cluster separation from malignant effusions. As such, it sets the stage for more nuanced cancer detection, ongoing monitoring, and the personalization of treatment strategies, heralding a promising future for cancer care.

    Source:

    Journal reference:

    Zhu, Z., et al. (2024). High-throughput and simultaneous inertial separation of tumor cells and clusters from malignant effusions using spiral-contraction-expansion channels. Microsystems & Nanoengineering. doi.org/10.1038/s41378-024-00661-0.

    [ad_2]

    Source link

  • NCCN 2024 Annual Conference focuses on practical applications for improving cancer care

    NCCN 2024 Annual Conference focuses on practical applications for improving cancer care

    [ad_1]

    The National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;hosted more than 1,700 oncology professionals during the NCCN 2024 Annual Conference on April 5-7. The yearly meeting includes opportunities for care providers to interact with world-renowned specialists on the latest evidence-based expert consensus recommendations for delivering high quality, patient-centered cancer care. Sessions focused on practical applications for improving care at every level, including clinical and administrative tracks, patient perspectives, and pressing policy issues.

    “The NCCN Annual Conference has always been one of my favorite events, because it is an opportunity to learn about both the clinical and administrative aspects of cancer care delivery with practical things I can take home and immediately apply,” said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN, who has been attending since her time as an oncology fellow, long before joining the organization. “Clinical practice guidelines and continuing education events such as NCCN’s Annual Conference democratize care and disseminate knowledge. They enable providers to know what appropriate care should be and how to deliver it so every patient can have access to care that aligns with their goals. I hope that everyone who attended our meeting learned something new, met someone new, and can implement something new when they go home so we can all work together to improve and facilitate quality, effective, equitable, and accessible cancer care for everyone.”

    The conference included a plenary session on the topic of drug shortages in oncology, with a discussion about both short-term mitigation strategies and long-term fixes. Speakers shared their personal experiences as patients and caregivers in addition to physicians and pharmacists navigating recent and longstanding experiences with concerning shortages of life-saving generic medications.

    According to Laura Bray, MBA, Founder and Chief Change Maker, Angels for Change: “Our supply chain is lacking in reliability; it breaks too often. It also lacks resiliency; when it breaks, it can’t recover quickly. Every link on the chain will have to make changes to end the ongoing crisis of dangerous and heartbreaking drug shortages. But if we do this right, everyone will only need to change a little bit in order to prevent drug shortages and save lives.”

    Congress needs to pass laws mandating more transparency around the supply chain of oncology drugs. If we’re going to solve this, lawmakers need to act.”


    Erin R. Fox, PharmD, MHA, BCPS, University of Utah Health Care

    Another plenary session provided patient and provider perspectives on managing hereditary cancer risk, such as Lynch syndrome.

    “Genetic testing helps people understand their risk for cancer, so they can take steps to reduce that risk and also make personalized medical decisions for their treatment,” said Wenora Johnson, 3x Cancer Survivor, Patient Advocate, FORCE. “For instance, lifelong surveillance is a must for me. Regular maintenance is my new norm, but I’m not mad about it, because it keeps me alive.”

    Other sessions delved into the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for numerous cancer types, including:

    • Acute Myeloid Leukemia
    • HR-Positive, HER2-Negative Breast Cancer
    • Localized Prostate Cancer
    • MSI-H/dMMR Upper and Lower Gastrointestinal Cancers
    • Metastatic Non-Small Cell Lung Cancer
    • Small Cell Lung Cancer
    • Locally Advanced Rectal Cancer
    • Renal Cell Carcinoma
    • Metastatic Urothelial Cancer
    • Multiple Myeloma
    • Endometrial Cancer
    • Cutaneous Melanoma
    • Basal Cell and Squamous Cell Skin Cancers
    • Neuroblastoma
    • Pancreatic Cancer
    • Recurrent/Metastatic Head and Neck Cancers

    Additional session topics included vaccination recommendations for cancer survivors, screening and supportive care approaches, and best practices for maximizing staffing and healthcare resources. A panel on Artificial Intelligence (AI) in Oncology looked into both the promise and the dangers of this emerging tool for harnessing big data with limited time. It was described as allowing physicians more time for interacting with patients, while letting computer algorithms sort the needles from the haystacks.

    “Using a piloted AI tool as a ‘Virtual Scribe’ gave me an hour of life back for every day I spend in clinic,” said Randa M. Perkins, MD, MBA, Moffitt Cancer Center. “But we do need transparency and a regulatory framework to ensure equity, fairness, and safety. Regulations may slow down production, but they will increase adoption; there will be more trust once we know there are sufficient guardrails in place.”

    The conference also featured nearly 200 poster presentations with original research on cancer care. In-person attendees had opportunities to join expert-led tours of the posters and hear oral presentations for the top-rated abstracts. There were additional opportunities for networking, including an interactive exhibit hall, a ‘Mingle for a Mission’ event assembling garden kits for breast cancer survivors, and frequent ‘Continue the Conversation’ opportunities to chat with speakers and attendees in a less formal setting.

    [ad_2]

    Source link

  • Unraveling the mysteries of gastro-esophageal junction development

    Unraveling the mysteries of gastro-esophageal junction development

    [ad_1]

    The transition from the esophagus to the stomach is a delicate region from a medical point of view, often associated with pathological disorders leading to cancer. An international research team has now gained new insights into this region. These pave the way for new prevention and treatment options.

    The meeting point of the stomach and esophagus, the so-called gastro-esophageal junction, is a region of the human body that is not well-suited to the modern lifestyle. Stress, alcohol, nicotine and severe obesity are often triggers for pathological changes to the mucosal membrane in this area, often resulting in esophageal cancer.

    An international research team has now gained new insights into the development of the cells, their communication with each other, and their regulation at the junction of the esophagus and stomach. With the help of specially developed mini-organs, so-called organoids, and with techniques that make it possible to track and profile individual cells, they have been able to follow the development of the gastro-esophageal junction from embryonic to adult stage in detail using animal experiments.

    New insights into the development of the gastrointestinal tract

    Their results reveal the complex communication at the cellular level and the specific pathways that these cells use to communicate. They provide new insights into the development of the gastro-esophageal junction and thus have significant implications for the understanding, prevention and treatment of gastrointestinal diseases. At the same time, they present new starting points for medical research and the development of new therapies.

    Cindrilla Chumduri is responsible for this study, which has now been published in the journal Nature Communications. Until recently, the infection and cancer biologist was a research group leader at the Department of Microbiology at Julius-Maximilians-Universität Würzburg (JMU); she is now an associate professor at Aarhus University (Denmark). Other participants came from Charité – Universitätsmedizin and the Max Planck Institute for Infection Biology in Berlin.

    “This collaboration underlines the importance of different expertise to improve our understanding of the biology of the gastrointestinal tract,” says Chumduri.

    She herself has many years of experience in research with organoids. Among other things, she has used mini-organs she developed to study how cells in the cervix degenerate and turn cancerous – another region where different types of mucosal cells collide.

    Where different epithelia meet

    The squamous epithelia of the esophagus and the columnar epithelia of the stomach meet at the gastroesophageal junction.”

    Dr. Naveen Kumar Nirchal, one of the first authors of the study

    The area is known as a “hotspot for the development of metaplasia” – the replacement of one type of cell by another.

    Barrett’s esophagus, a precursor to esophageal cancer, often develops there, the number of cases of which has increased dramatically in the Western world over the past four decades. “Barrett’s esophagus is characterized by the replacement of the resident squamous epithelium of the esophagus by other cell types that are not normally found in this tissue,” says the scientist.

    However, it is still unclear why this region is so susceptible to this process. In order to better understand this transformation, it is therefore first necessary to decipher the normal development process in detail – from embryo to mature adult. “This is the only way to determine the tissue changes that trigger the progression of the disease, explains Dr. Rajendra Kumar Gurumurthy, another researcher of the study.

    A never-before-seen insight into the development of this region

    This has now been achieved: By using a novel approach that combines organoid and mouse models with advanced single-cell transcriptome analyses over time and space, the research team has shed light on the complex developmental process of the gastroesophageal junction. “We were able to provide unprecedented insight into the development of this region from the embryonic stage to adulthood in mice and identify the intricate composition of the cells involved and how they develop,” explains Pon Ganish Prakash, another scientist involved in the study.

    The work shows the sophisticated communication between different cell types within the gastroesophageal junction and the signaling pathways involved. “This understanding opens up new avenues for research into gastrointestinal diseases,” says Cindrilla Chumduri.

    Above all, the precision of the single-cell analysis in their study opens new doors to understanding how pathological processes develop and to developing innovative treatments, the team writes in its study. The work will therefore be a “cornerstone for understanding the development of such diseases” and will significantly influence the approach to the early detection and treatment of diseases in this important part of the digestive system.

    Source:

    Journal reference:

    Kumar, N., et al. (2024). Decoding spatiotemporal transcriptional dynamics and epithelial fibroblast crosstalk during gastroesophageal junction development through single cell analysis. Nature Communications. doi.org/10.1038/s41467-024-47173-z.

    [ad_2]

    Source link

  • Study reveals how DNA gyrase resolves DNA entanglements

    Study reveals how DNA gyrase resolves DNA entanglements

    [ad_1]

    Picture in your mind a traditional “landline” telephone with a coiled cord connecting the handset to the phone. The coiled telephone cord and the DNA double helix that stores the genetic material in every cell in the body have one thing in common; they both supercoil, or coil about themselves, and tangle in ways that can be difficult to undo. In the case of DNA, if this overwinding is not dealt with, essential processes such as copying DNA and cell division grind to a halt. Fortunately, cells have an ingenious solution to carefully regulate DNA supercoiling.

    In this study published in the journal Science, researchers at Baylor College of Medicine, Université de Strasbourg, Université Paris Cité and collaborating institutions reveal how DNA gyrase resolves DNA entanglements. The findings not only provide novel insights into this fundamental biological mechanism but also have potential practical applications. Gyrases are biomedical targets for the treatment of bacterial infections and the similar human versions of the enzymes are targets for many anti-cancer drugs. Better understanding of how gyrases work at the molecular level can potentially improve clinical treatments.

    Some DNA supercoiling is essential to make DNA accessible to allow the cell to read and make copies of the genetic information, but either too little or too much supercoiling is detrimental. For example, the act of copying and reading DNA overwinds it ahead of the enzymes that read and copy the genetic code, interrupting the process. It’s long been known that DNA gyrase plays a role in untangling the overwinding, but the details were not clear.

    DNA minicircles and advanced imaging techniques reveal first step to untangle DNA

    We typically picture DNA as the straight double helix structure, but inside cells, DNA exists in supercoiled loops. Understanding the molecular interactions between the supercoils and the enzymes that participate in DNA functions has been technically challenging, so we typically use linear DNA molecules instead of coiled DNA to study the interactions. One goal of our laboratory has been to study these interactions using a DNA structure that more closely mimics the actual supercoiled and looped DNA form present in living cells.”


    Dr. Lynn Zechiedrich, study author, Kyle and Josephine Morrow Chair in Molecular Virology and Microbiology and professor of the Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology at Baylor College of Medicine

    After years of work, the Zechiedrich lab has created small loops of supercoiled DNA. In essence, they took the familiar straight linear DNA double helix and twisted it in either direction once, twice, three times or more and connected the ends together to form a loop. Their previous study looking at the 3-D structures of the resulting supercoiled minicircles revealed that these loops form a variety of shapes that they hypothesized enzymes such as gyrase would recognize.

    In the current study, their hypothesis was proven correct. The team of researchers combined their expertise to study the interactions of DNA gyrase with DNA minicircles using recent technology advances in electron cryomicroscopy, an imaging technique that produces high-resolution 3-D views of large molecules, and other technologies.

    “My lab has long been interested in understanding how molecular nanomachines operate in the cell. We have been studying DNA gyrases, very large enzymes that regulate DNA supercoiling,” said co-corresponding author Dr. Valérie Lamour, associate professor at the Institut de Génétique et de Biologie Moléculaire et Cellulaire, Université de Strasbourg. “Among other functions, supercoiling is the cell’s way of confining about 2 meters (6.6 feet) of linear DNA into the microscopic nucleus of the cell.”

    As the DNA supercoils inside the nucleus, it twists and folds in different forms. Imagine twisting that telephone cord mentioned at the beginning, several times on itself. It will overwind and form a loop by crossing over DNA chains, tightening the structure.

    “We found, just as we had hypothesized, that gyrase is attracted to the supercoiled minicircle and places itself in the inside of this supercoiled loop,” said co-author, Dr. Jonathan Fogg, senior staff scientist of molecular virology and microbiology, and biochemistry and molecular pharmacology in the Zechiedrich lab.

    “This is the first step of the mechanism that prompts the enzyme for resolving DNA entanglements,” Lamour said.

    “DNA gyrase, now surrounded by a tightly supercoiled loop, will cut one DNA helix in the loop, pass the other DNA helix through the cut in the other, and reseal the break, which relaxes the overwinding and eases the tangles, regulating DNA supercoiling to control DNA activity,” Zechiedrich said. “Imagine watching the rodeo. Like roping cattle with a lasso, supercoiled looped DNA captures gyrase in the first step. Gyrase then cuts one double-helix of the DNA lasso and passes the other helix through the break to get free.”

    Co-corresponding author, Dr. Marc Nadal, professor at the École Normale in Paris confirmed the observation of the path of the DNA wrapped in the loop around gyrase using magnetic tweezers, a biophysical technique that allows to measure the deformation and fluctuations in the length of a single molecule of DNA. Observing a single molecule provides information that is often obscured when looking at thousands of molecules in traditional so-called “ensemble” experiments in a test tube.

    Interestingly, the “DNA strand inversion model” for gyrase activity was proposed in 1979 by Drs. Patrick O. Brown and the late Nicholas R. Cozzarelli, also in a Science paper, well before researchers had access to supercoiled minicircles or the 3-D molecular structure of the enzyme. “It’s especially meaningful to me that 45 years later, we finally provide experimental evidence supporting their hypothesis because Nick was my postdoctoral mentor,” Zechiedrich said.

    “This work opens a myriad of perspectives to study the mechanism of this conserved class of enzymes, which are of great clinical value,” Lamour said.

    “This work supports new ideas on how DNA activities are regulated. We propose that DNA is not a passive biomolecule acted upon by enzymes, but an active one that uses supercoiling, looping and 3-D shapes to direct accessibility of enzymes such as gyrase to specific DNA sequences in a variety of situations, which will likely impact cellular responses to antibiotics or other treatments,” Fogg said.

    Contributors to this work also include Marlène Vayssières (lead author), Nils Marechal, Long Yun, Brian Lopez Duran and Naveen Kumar Murugasamy. The authors are affiliated with one or more of the following institutions: Baylor College of Medicine, Université de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM, Université Paris and Hôpitaux Universitaires de Strasbourg.

    Source:

    Journal reference:

    Vayssières, M., et al. (2024) Structural basis of DNA crossover capture by Escherichia coli DNA gyrase. Science. doi.org/10.1126/science.adl5899.

    [ad_2]

    Source link

  • Nanopore sequencing unveils novel telomere length patterns

    Nanopore sequencing unveils novel telomere length patterns

    [ad_1]

    We depend on our cells being able to divide and multiply, whether it’s to replace sunburnt skin or replenish our blood supply and recover from injury. Chromosomes, which carry all of our genetic instructions, must be copied in a complete way during cell division. Telomeres, which cap the ends of chromosomes, play a critical role in this cell-renewal process-;with a direct bearing on health and disease.

    The enzyme telomerase plays a key role in maintaining the length of telomeres as chromosomes replicate during cell division. UC Santa Cruz professor Carol Greider has been studying telomeres and telomerase for over 30 years. The impact of the discoveries she has made over that time are why she, along with two colleagues, won the Nobel Prize in Physiology or Medicine in 2009.

    So, the findings of Greider’s latest study on telomeres shouldn’t have surprised her. And yet, they did.

    Published online today in Science, a new study finds that telomere lengths follow a different pattern than has thus far been understood. Instead of telomere lengths falling under one general range of shortest to longest across all chromosomes, this study finds that different chromosomes have separate end-specific telomere-length distributions.

    According to Greider, this discovery means we don’t fully understand the molecular process that regulates telomere lengths. And that’s important because of how telomere lengths affect human health: “When telomeres get to be too short, you have age-related degenerative diseases like pulmonary fibrosis, bone-marrow failure, and immunosuppression,” Greider said. “On the other hand, if telomeres are too long, it predisposes you to certain types of cancer.”

    Kayarash Karimian, the lead author on the paper, is a former Ph.D. student in Greider’s lab at the Johns Hopkins University School of Medicine. Other co-authors of this study include researchers at the Dana-Farber Cancer Institute, Harvard Medical School, and University of Pittsburgh. Greider, a distinguished professor of molecular, cell, and developmental biology at UC Santa Cruz, and a University Professor at Johns Hopkins, was the senior author on the paper and led the work.

    Why length matters

    Without telomerase, telomeres would get shorter and shorter as a cell divides over and over again. Over the past 30 years, research by Greider and others have confirmed that short telomeres lead to degenerative disease-;as well as shown that telomere lengths fall within a certain range.

    But this paper challenges scientific consensus by showing that a singular telomere-length range is too broad. Measuring the telomeres of 147 people for this study, the researchers found in one individual that the average telomere length across all chromosomes was 4,300 bases of DNA. Then when they isolated specific chromosomes, they found most telomere lengths differed significantly from this average. In one case, lengths differed as much as 6,000 bases, which Greider describes as “jaw dropping.”

    Further, they found across all 147 individuals the same telomeres were most often the shortest or longest, implying telomeres on specific chromosome ends may be the first to trigger stem-cell failure.

    Innovating on nanopore sequencing

    To make such precise measurements at the molecular level, Greider’s team used a technique invented at UC Santa Cruz called “nanopore sequencing,” a revolutionary method for reading DNA and RNA that has had an immense impact on genomics research since its 2014 debut on the market as the commercial product MinION.

    Nanopore technology has enabled some of the most significant advances in the genomics field, such as the completion of a gapless human genome, and sequencing of COVID-19 genomes-;making it crucial in the fight to end the pandemic. UC Santa Cruz licensed the concept for nanopore-sequencing technology to the UK-based company Oxford Nanopore Technologies, which made MinION, the first hand-held DNA sequencer.

    Notably, in the eyes of nanopore sequencing’s inventors, Greider’s study proves that the technique’s ability to advance scientific research continues to unfold. Mark Akeson, emeritus professor of biomolecular engineering at UC Santa Cruz, notes that two preprint studies that corroborate the basic findings of Greider’s paper have also been posted online.

    In my opinion, this is the most important nanopore-based paper focused on human biology since the MinION was introduced. It is easy to envision broad use of their telomere-length assay in the clinic.”


    Mark Akeson, emeritus professor of biomolecular engineering at UC Santa Cruz

    Akeson and David Deamer, also an emeritus professor of biomolecular engineering at the Baskin School of Engineering, were honored at the Library of Congress last year for inventing nanopore sequencing. Their colleague and friend Daniel Branton, a Havard biologist and co-inventor of the technology, was honored as well.

    Implications for disease prevention

    Such precise DNA reads allowed Greider’s team to pinpoint the sequences adjacent to telomeres and hypothesize that those areas are where telomerase is regulating length. And if that’s true, Greider said those regions, and the proteins that bind there, could serve as potential targets for new drugs for preventing disease.

    In addition, their process of “telomere profiling” via nanopore sequencing could serve as a model for the development of additional MinION-based assays for high-throughput drug screening.

    “This accessible technique has widespread potential for use in research, diagnostics, and drug development,” Greider said. “This work indicates that there are yet undiscovered mechanisms for telomere length regulation; probing these mechanisms will inform new approaches to cancer and certain degenerative diseases.”

    The study, “Human telomere length is chromosome end-specific and conserved across individuals,” was funded by grants from the National Institutes of Health (R35CA209974 to Greider and R01HL166265), the Johns Hopkins Bloomberg Distinguished Professorship, and the National Science Foundation Graduate Research Fellowship Program.

    Source:

    Journal reference:

    Karimian, K., et al. (2024) Human telomere length is chromosome end–specific and conserved across individuals. Science. doi.org/10.1126/science.ado0431.

    [ad_2]

    Source link

  • Blocking polyphosphates could help treat chronic infections

    Blocking polyphosphates could help treat chronic infections

    [ad_1]

    Most disease-causing bacteria are known for their speed: In mere minutes, they can double their population, quickly making a person sick. But just as dangerous as this rapid growth can be a bacterium’s resting state, which helps the pathogen evade antibiotics and contributes to severe chronic infections in the lungs and blood, within wounds, and on the surfaces of medical devices.

    Now, Scripps Research scientists have discovered how long chains of molecules called polyphosphates (polyP) are needed for bacteria to slow down movements within cells and let them enter this resting state. The findings, published in Proceedings of the National Academy of Sciences on April 02, 2024, could eventually lead to new ways of treating chronic infections in which typical antibiotics aren’t effective.

    Many current antibiotics block bacterial growth, but bacteria spend a lot of their time not growing. We really need new and creative strategies for targeting bacteria’s slow-growing and non-growing phases.”


    Lisa Racki, assistant professor in the Department of Integrative Structural and Computational Biology at Scripps Research and senior author of the new paper

    Researchers have long known that bacteria can survive for especially long periods of time when they stop growing, entering a dormant and energy-saving state. They also knew that when bacteria enter this resting state, they use valuable energy to produce polyP strands, which form large clumps inside their cells. But scientists had been historically unsure about the purpose of polyP.

    To study polyP, Racki and her collaborators turned to Pseudomonas aeruginosa, bacteria that can cause pneumonia and blood infections in people who are hospitalized or have weakened immune systems. One of the reasons P. aeruginosa can be so hard to treat is that it forms biofilms-;tightly joined, slimy communities of bacteria, many of which are in a resting state and can evade typical antibiotics.

    When P. aeruginosa is starved of nitrogen-;one of the key nutrients it needs for growth-;it produces lots of polyP. In the new work, Racki and her collaborators at EPFL and Caltech discovered that a mutant unable to make polyP cannot enter its resting state. To better understand why this happens and the consequences, the researchers genetically engineered P. aeruginosa to make small, labeled particles that let them track how molecules within the bacteria were moving around.

    “What we found is that when you get rid of polyP, everything in the cell moves too much,” says Racki. “The cells are partying when they should be taking a break.”

    When starved of most nutrients, P. aeruginosa slows the movement of materials within its interior and stops dividing. But without nitrogen and polyP, the bacteria keep moving materials around at top-speed, become bigger, loosen their genetic material and continue dividing.

    Racki’s team concluded that polyP is usually responsible for helping P. aeruginosa-;and likely other bacterial species-;slow down. It also leads them to hypothesize that preventing cells from producing polyP could keep them active and make them more susceptible to some antibiotics.

    “This not only helps point in possible directions for treating pathogenic bacteria, but also reveals answers for fundamental questions about how things diffuse throughout a bacterial cell,” says Racki.

    Racki and her lab are now planning more experiments to better probe exactly why cells cannot slow their interior movements without polyP, and whether blocking the bacterial production of polyP could be an effective tactic to treat some infections.

    Source:

    Journal reference:

    Magkiriadou, S., et al. (2024). Polyphosphate affects cytoplasmic and chromosomal dynamics in nitrogen-starved Pseudomonas aeruginosaProceedings of the National Academy of Sciences. doi.org/10.1073/pnas.2313004121.

    [ad_2]

    Source link

  • Research offers insights into facial development at the cellular level

    Research offers insights into facial development at the cellular level

    [ad_1]

    Mother Nature is an artist, but her craft of creating animal faces requires more than a paintbrush and palette. Such highly complex shapes originate from their respective transient neural crest cells

    These embryonic pluripotent cells within the facial primordium-;the early development form-;may be necessary for forming proper facial structures. However, analyzing the molecular mechanisms in such early stages of development poses many technical challenges.

    Now, a group of Kyoto University researchers have produced neural crest cell-rich aggregates from human pluripotent stem cells and developed a method to differentiate them in cell populations with a branchial arch-like gene expression pattern. 

    After the cell populations differentiate into precursors of maxillary and mandibular cells in response to external signaling factors, these populations spontaneously form patterns of the facial primordium.”


    Yusuke Seto of KyotoU’s Institute for Medical and Biological Research

    This cartilage-like structure, reminiscent of Meckel‘s cartilage, is formed locally within the aggregates.

    “We aim to establish a model for studying early facial development by using the properties of human pluripotent stem cells to generate in vitro tissue resembling the bronchial arch of the primordial face,” adds Ryoma Ogihara, also of the Institute.

    Researchers are examining the various developmental processes that cause interspecific and individual differences in facial structure to explain conditions such as craniofacial disorders.

    “Using our in vitro model could help us better understand and control signal integration during the fate determination of the branchial arch and cartilage formation in the face and elsewhere. We hope our technology can contribute to the development of cellular materials for new regenerative medicine,” adds Mototsugu Eiraku, also of the Institute.

    Source:

    Journal reference:

    Seto, Y., et al. (2024). In vitro induction of patterned branchial arch-like aggregate from human pluripotent stem cells. Nature Communications. doi.org/10.1038/s41467-024-45285-0.

    [ad_2]

    Source link

  • Visualizing centriole genesis with microscopy and kinematic reconstruction techniques

    Visualizing centriole genesis with microscopy and kinematic reconstruction techniques

    [ad_1]

    Cells contain various specialized structures – such as the nucleus, mitochondria or peroxisomes – known as “organelles”. Tracing their genesis and determining their structure is fundamental to understanding cell function and the pathologies linked to their dysfunction. Scientists at the University of Geneva (UNIGE) have combined high-resolution microscopy and kinematic reconstruction techniques to visualize, in motion, the genesis of the human centriole. This organelle, essential to the organization of the cell skeleton, is associated – in case of dysfunction – with certain cancers, brain disorders or retinal diseases. This work, published in the journal Cell, elucidates the complexities of centriole assembly. It also opens up many new avenues for the study of other cell organelles.

    Organelle genesis proceeds according to a precise sequence of successive protein recruitment events. Visualizing this assembly in real-time provides a better understanding of the role of these proteins in organelle structure or function. However, obtaining a video sequence with sufficient resolution to distinguish such complex microscopic components faces a number of technical limitations.

    Inflating cells for better observation

    This is particularly true of the centriole. This organelle, measuring less than 500 nanometers (half a thousandth of a millimeter), is constituted of around 100 different proteins organized into six substructural domains. Until a few years ago, it was impossible to visualize the structure of the centriole in detail. The laboratory of Paul Guichard and Virginie Hamel, co-directors of research in the Department of Molecular and Cellular Biology at the UNIGE Faculty of Science, has changed this situation by using the technique of expansion microscopy. This cutting-edge technique enables cells and their constituents to be progressively inflated without being deformed, so that they can then be observed – using conventional microscopes – with very high resolution.

    Obtaining images of the centriole with such high resolution enables the exact location of proteins at a given time but gives no information on the order of appearance of substructural domains or of individual proteins. Marine Laporte, a former research and teaching fellow in the UNIGE group and first author of the study, used expansion microscopy to analyze the location of 24 proteins in the six domains in over a thousand centrioles at different stages of growth.

    Reorganizing images to set them in motion 

    ”This very tedious work was followed by a pseudo-temporal kinematic reconstruction. In other words, we were able to put these thousands of images taken at random during centriole biogenesis back into chronological order, to reconstruct the various stages in the formation of centriole substructures, using a computer analysis we developed,” explains Virginie Hamel, co-leader of the study.

    This unique approach, which combines the very high resolution of expansion microscopy and kinematic reconstruction, has enabled us to model the first 4D assembly of the human centriole.

    Our work will not only deepen our understanding of centriole formation, but also open up incredible prospects in cellular and molecular biology, since this method can be applied to other macromolecules and cellular structures to study their assembly in space and time.” 


    Paul Guichard, Department of Molecular and Cellular Biology, UNIGE Faculty of Science

    Source:

    Journal reference:

    Laporte, M. H., et al. (2024) Time-series reconstruction of the molecular architecture of human centriole assembly. Cell. doi.org/10.1016/j.cell.2024.03.025.

    [ad_2]

    Source link

  • Geraniol alleviates cognitive decline in D-galactose-induced aging mice

    Geraniol alleviates cognitive decline in D-galactose-induced aging mice

    [ad_1]

    A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 6, entitled, “Geraniol attenuates oxidative stress and neuroinflammation-mediated cognitive impairment in D galactose-induced mouse aging model.”

    D-galactose (D-gal) administration was proven to induce cognitive impairment and aging in rodents’ models. Geraniol (GNL) belongs to the acyclic isoprenoid monoterpenes. GNL reduces inflammation by changing important signaling pathways and cytokines, and thus it is plausible to be used as a medicine for treating disorders linked to inflammation. In this new study, researchers Peramaiyan Rajendran, Fatma J. Al-Saeedi, Rebai Ben Ammar, Basem M. Abdallah, Enas M. Ali, Najla Khaled Al Abdulsalam, Sujatha Tejavat, Duaa Althumairy, Vishnu Priya Veeraraghavan, Sarah Abdulaziz Alamer, Gamal M. Bekhet, and Emad A. Ahmed from King Faisal University, Kuwait University, Center of Biotechnology of Borj-Cedria, Saveetha University, Alexandria University, and Assiut University examined the therapeutic effects of GNL on D-gal-induced oxidative stress and neuroinflammation-mediated memory loss in mice. 

    “Life expectancy in the 21st century is rising, resulting in more age-related illnesses, such as memory impairment and Alzheimer’s disease. In this study, GNL was studied for its protective effect on D-gal-induced aging in mice.”

    The study was conducted using six groups of mice (6 mice per group). The first group received normal saline, then D-gal (150 mg/wt) dissolved in normal saline solution (0.9%, w/v) was given orally for 9 weeks to the second group. In the III group, from the second week until the 10th week, mice were treated orally (without anesthesia) with D-gal (150 mg/kg body wt) and GNL weekly twice (40 mg/kg body wt) four hours later. Mice in Group IV were treated with GNL from the second week up until the end of the experiment. For comparison of young versus elderly mice, 4 month old (Group V) and 16-month-old (Group VI) control mice were used. 

    “We evaluated the changes in antioxidant levels, PI3K/Akt levels, and Nrf2 levels. We also examined how D-gal and GNL treated pathological aging changes.”

    Administration of GNL induced a significant increase in spatial learning and memory with spontaneously altered behavior. Enhancing anti-oxidant and anti-inflammatory effects and activating PI3K/Akt were the mechanisms that mediated this effect. Further, GNL treatment upregulated Nrf2 and HO-1 to reduce oxidative stress and apoptosis. This was confirmed using 99mTc-HMPAO brain flow gamma bioassays. 

    “Thus, our data suggested GNL as a promising agent for treating neuroinflammation-induced cognitive impairment.”

    Source:

    Journal reference:

    Rajendran, P., et al. (2024). Geraniol attenuates oxidative stress and neuroinflammation mediated cognitive impairment in D galactose induced mouse-aging model. Aging. doi.org/10.18632/aging.205677.

    [ad_2]

    Source link